Inventor · disambiguated record
Matthew R. Kaller
Also filed as: KALLER MATTHEW · KALLER MATTHEW R · KALLER MATTHEW RICHARD
28 granted patents·7 pending applications·168 citations·filing 2004–2021
96Inventor score
Top patents by PatentIndex Score
35 records- 0198US9573936B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Feb 21, 2017·19 cites·56 claims
- 0297US10221162B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2018·Granted Mar 5, 2019·12 cites·22 claims
- 0397US10058550B2Methods of treating heart failureAMGEN INC·Filed 2017·Granted Aug 28, 2018·13 cites·81 claims
- 0497US9868721B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Jan 16, 2018·14 cites·60 claims
- 0597US9745286B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Aug 29, 2017·16 cites·52 claims
- 0697US9656998B2Intermediates for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted May 23, 2017·14 cites·16 claims
- 0795US9845310B2Intermediates for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Dec 19, 2017·14 cites·16 claims
- 0895US9751864B2Methods for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Sep 5, 2017·14 cites·28 claims
- 0995US9656997B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted May 23, 2017·16 cites·46 claims
- 1093US10632128B2Compounds that inhibit Mcl-1 proteinAMGEN INC·Filed 2019·Granted Apr 28, 2020·5 cites·49 claims
- 1182US9303028B2Azetidine and piperidine compounds useful as PDE10 inhibitorsAMGEN INC·Filed 2014·Granted Apr 5, 2016·4 cites·18 claims
- 1282US9096527B2TRPM8 antagonists and their use in treatmentsAMGEN INC·Filed 2014·Granted Aug 4, 2015·5 cites·38 claims
- 1380US11046680B1Heteroaryl-substituted triazoles as APJ receptor agonistsAMGEN INC·Filed 2017·Granted Jun 29, 2021·2 cites·33 claims
- 1480US9376450B2Heteroaryloxyheterocyclyl compounds as PDE10 inhibitorsAMGEN INC·Filed 2013·Granted Jun 28, 2016·4 cites·26 claims
- 1580US8691986B2Azetidine and piperidine compounds useful as PDE10 inhibitorsAMGEN INC·Filed 2013·Granted Apr 8, 2014·3 cites·8 claims
- 1679US8497265B2Heteroaryloxyheterocyclyl compounds as PDE10 inhibitorsALLEN JENNIFER R·Filed 2011·Granted Jul 30, 2013·4 cites·16 claims
- 1779US8318718B2Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitorsALLEN JENNIFER R·Filed 2009·Granted Nov 27, 2012·4 cites·94 claims
- 1877US8637500B2Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitorsALLEN JENNIFER R·Filed 2009·Granted Jan 28, 2014·3 cites·18 claims
- 1975US12441736B2KIF18A inhibitorsAMGEN INC·Filed 2019·Granted Oct 14, 2025·1 cites·31 claims
- 2072US11224601B1Compounds that inhibits MCL-1 proteinAMGEN INC·Filed 2020·Granted Jan 18, 2022·0 cites·15 claims
- 2170US8778941B2TRPM8 antagonists and their use in treatmentsBROWN JAMES·Filed 2012·Granted Jul 15, 2014·1 cites·33 claims
- 2269US10821115B2Compounds that inhibit Mcl-1 proteinAMGEN INC·Filed 2020·Granted Nov 3, 2020·0 cites·43 claims
- 2357US9493459B2Azetidine and piperidine compounds useful as PDE10 inhibitorsAMGEN INC·Filed 2016·Granted Nov 15, 2016·0 cites·3 claims
- 2456US2023406860A1Heterocyclic spiro compounds and methods of useAMGEN INC·Filed 2021·Application pending·0 cites
- 2555US8710043B2TRPM8 antagonists and their use in treatmentsCHEN JIAN J·Filed 2012·Granted Apr 29, 2014·0 cites·40 claims
- 2655US2024059703A1Heterocyclic spiro compounds and methods of useAMGEN INC·Filed 2021·Application pending·0 cites
- 2752US12435058B2KIF18A inhibitorsAMGEN INC·Filed 2020·Granted Oct 7, 2025·0 cites·21 claims
- 2852US2023159510A1Novel prmt5 inhibitorsAMGEN INC·Filed 2021·Application pending·0 cites
- 2952US2007032518A1Compounds and methods of useAMGEN INC·Filed 2004·Application pending·0 cites
- 3052US2014235642A1Trpm8 antagonists and their use in treatmentsAMGEN INC·Filed 2014·Application pending·0 cites
- 3151US2022289724A1Kif18a inhibitorsAMGEN INC·Filed 2020·Application pending·0 cites
- 3249US8759532B2Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitorsAMGEN INC·Filed 2012·Granted Jun 24, 2014·0 cites·80 claims
- 3348US2015031668A1Chroman derivatives as trpm8 inhibitorsAMGEN INC·Filed 2014·Application pending·0 cites
- 3446US8952009B2Chroman derivatives as TRPM8 inhibitorsAMGEN INC·Filed 2013·Granted Feb 10, 2015·0 cites·57 claims
- 3543US8476297B2TRP-M8 receptor ligands and their use in treatmentsNORMAN MARK H·Filed 2008·Granted Jul 2, 2013·0 cites·11 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →